Revolutions Medical, www.revolutionsmedical.com – the leading developers of safety-engineered medical devices like the RevVac™ Safety Syringe, as well as revolutionary medical software tools like the RevColor™, RevDisplay™ and Rev3D™ imaging platforms, reported a breakthrough today, advancing the state of automatic retractable prefilled safety syringe technology to the next level.

CEO of RMCP, Ron Wheet, explained that the Company, building upon its established proficiency in automatic prefilled syringes, has extended its proprietary vacuum-based technology with what he considers an unparalleled offering that will define a new gold standard in safety syringes.

The new enhancements will provide a degree of blanket protection against needle stick injury that crushes all competitors within the industry and is destined to set RMCP up as a provider of choice in prefilled syringes.

With some 50 drugs currently being administered via prefilled syringes, a $45B combined market in 2007 alone – the potential market capitalization for this breakthrough technology is quite impressive and should spell substantial returns for RMCP shareholders in 2011.

Wheet emphasized the elegant yet robust vacuum design which boasts a very few number of parts and the extended shelf life of the product, driving the superiority of the product home by citing the categorically lower price point than any competing technology on the market.

With plans to file more patents shortly in order to shore up this lucrative advancement, RMCP is rapidly positioning to compete at the forefront of the prefilled syringe market and is acting to fulfill the potential for extensive partnerships with pharmaceutical companies based on the technology.

The capacity exists here for pharmaceutical companies to offer a vastly superior and eminently safer product to their customers and to do so at a significantly reduced cost, great news for pharmaceutical companies who have already discovered the benefits of prefilled syringes.

From the drastically improved marketability to healthcare workers and reduced dosage waste, to the extremely attractive ability for patients to self administer doses easily in the comfort of their own homes, the prefilled safety syringe has many benefits which make the market incredibly dynamic.

Such powerful organic drivers have spelled massive growth for the prefilled market and projections indicate global manufacture of some 3B+ prefilled syringes in 2011.

On schedule to ship an initial order of 3ml RevVac fixed needle safety syringes this April and a subsequent order of 1ml RevVac’s in July via its fully-equipped Chinese manufacturer, RMCP anticipates final production samples and taking of its first orders by the middle of March.